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Abstract
Mesenchymal stem cells (MSC) are capable of multipotent 
differentiation into connective tissues and as such are an 
attractive source for autologous cell-based treatments for 
many clinical diseases and injuries. Ageing is associated 
with various altered cellular phenotypes coupled with 
a variety of transcriptional, epigenetic and translational 
changes. Furthermore, the regeneration potential of MSCs is 
reduced with increasing age and is correlated with changes 
in cellular functions. This study used a systems biology 
approach to investigate the transcriptomic (RNASeq), 
epigenetic (miRNASeq and DNA methylation) and protein 
alterations in ageing MSCs in order to understand the 
age-related functional and biological variations, which 
may affect their applications to regenerative medicine. 
We identified no change in expression of the cellular 
senescence markers. Alterations were evident at both 
the transcriptional and post-transcriptional level in a 
number of transcription factors. There was enrichment in 
genes involved in developmental disorders at mRNA and 
differential methylated loci (DML) level. Alterations in 
energy metabolism were apparent at the DML and protein 
level. The microRNA miR-199b-5p, whose expression was 
reduced in old MSCs, had predicted gene targets involved 
in energy metabolism and cell survival. Additionally, 
enrichment of DML and proteins in cell survival was 
evident. Enrichment in metabolic processes was revealed 
at the protein level and in genes identified as undergoing 
alternate splicing. Overall, an altered phenotype in MSC 
ageing at a number of levels implicated roles for inflamm-
ageing and mitochondrial ageing. Identified changes 
represent novel insights into the ageing process, with 
implications for stem cell therapies in older patients.
Keywords: Mesenchymal stem cells, RNAseq, epigenetics, 
proteomics, ageing.
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Introduction
Mesenchymal stem cells (MSC) are post-embryonic cells, 
capable of self- renewal and multipotent differentiation into 
connective tissues including bone, tendon and cartilage. 
They are an attractive source for autologous cell-based 
treatments for a range of clinical diseases and injuries. 
Furthermore, these cells may be considered useful tools 
for understanding the physiopathological understanding 
of specific diseases, and to develop disease-specific 
biomarkers (Valenti et al., 2015).
 MSCs possess an age-related loss of cellular functions, 
including differentiation potential and capacity for 
proliferation (Huang et al., 2010; Kretlow et al., 2008; Yu 
et al., 2011). This has implications for stem cell therapies 
in older patients. Moreover, the reduction in differentiation 
potential could contribute to ageing and age-related disease 
(Zaim et al., 2012). It has become increasingly apparent 
that the therapeutic efficacy mediated by MSCs is through 
the production of soluble factors (cytokines and growth 
factors) that control diverse disease-associated processes, 
including activation of tissue resident stem cells, apoptosis 
and inhibition of inflammation (Kolf et al., 2007).
 Ageing is a complex process with effects at both the 
cellular and organism level. Ageing has been defined 
as “the sum of the primary restrictions in regenerative 
mechanisms of multicellular organisms” (Sethe et al., 
2006). It presents huge challenges for society, but a key 
issue is that whilst life span increases, quality of life 
faced by individuals in old age is often poor. As MSCs 
provide regenerative capacity it is rational that functional 
deficiencies may contribute to the ageing process and 
age-related diseases such as osteoarthritis, osteoporosis 
and tendinopathy.
 Natural ageing is coupled with a progressive reduction 
in the regulation of cellular, tissue and organ interactions, 
resulting in senescence (the irreversibly arrest of cellular 
division). It can affect the decline in regenerative potential 
of tissue and cellular functions in numerous organs. Animal 
studies and clinical trials have demonstrated that the 
regeneration potential of bone (Stenderup et al., 2004) and 
other tissues declines with age due to a reduced number 
or frequency of stem cells present in adult organs. These 
factors could contribute to human ageing and age-related 
disease (Rando, 2006). Thus, understanding the age-related 
functional and biological alterations in MSCs will be 
decisive to the success of therapeutic application of MSCs. 
Furthermore, it is proposed that long-term culture and 
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ageing may be regulated by similar mechanisms (Wagner 
et al., 2009).
 A number of studies have investigated biological 
ageing on MSCs (reviewed by: Oh et al., 2014; Sethe et 
al., 2006; Stolzing et al., 2008). The cell number (Kasper 
et al., 2009; Sethe et al., 2006), potential to proliferate 
and differentiate (Kretlow et al., 2008; Zaim et al., 2012), 
frequency of colony forming units (Baxter et al., 2004) 
and senescence-associated beta-galactosidase (Zhou et al., 
2008) are age-related. Additionally, MSC ageing is affected 
by oxidative stress (Stolzing et al., 2006), DNA damage 
(Beausejour, 2007), telomere shortening (Beausejour, 
2007) and apoptosis (Stolzing et al., 2008). Using 
microarrays differentially expressed genes engaged in cell 
cycle. DNA replication and repair have been identified as 
age-related (Hacia et al., 2008; Yu et al., 2011), whilst 
a number of miRs are differentially expressed in MSC 
ageing (Pandey et al., 2011; Wagner et al., 2008; Yu et 
al., 2011). Global proteomic studies of biological MSC 
ageing have been scarce, although studies have investigated 
in vitro ageing (Madeira et al., 2012) and MSCs in old 
osteoarthritis patients (Camafeita et al., 2014; Rollin et al., 
2008). However, one study in the rat identified age-affected 
susceptibility towards senescence, and molecular functions 
associated with cytoskeleton organisation and antioxidant 
defence (Kasper et al., 2009). Previous studies have shown 
that genes involved in cell signalling, apoptosis and cell 
death undergo differential methylation in late passage 
MSCs when compared to early passage MSCs (Choi et 
al., 2012; Redaelli et al., 2012). In addition, analysis of 
methylation in biological ageing identified differentially 
methylated homeobox genes and genes pertinent to cell 
differentiation (Bork et al., 2010).
 Important bio-molecules in MSC ageing consist of the 
genes functioning as the information source defining limits 
of cell behaviour. Some of this information is processed 
through transcription, forming mRNA. This can be 
regulated by methylation and miRNA epigenetic control. 
mRNA transcription enables the production of proteins, 
the effector molecules that control the cellular state and 
behaviour. The purpose of this study was to investigate the 
global epigenetic (DNA-methylation and miRNA), RNA 
and protein changes in biological ageing of MSCs in a bid 
to understand the age-related functional and biological 
changes impacting upon their therapeutic applications 
in regenerative medicine and use as disease-specific 
biomarkers. The identification of individual transcripts, 
functionally coherent gene sets, or proteins that are under- 
or over-expressed with ageing may provide key insights 
into the mechanisms of ageing processes and age-related 
disease.
Materials and Methods
Mesenchymal stem cell culture
Human MSCs were purchased from young; n = 4 
(21.8 y ± 2.4 SD) (Stem Cell Technologies, Grenoble, 
France) and old; n = 4 (65.5 y ± 8.3 SD) (Promocell, 
Heidelberg, Germany) donors and RNA, DNA and protein 
extracted following 8 population doublings. MSCs were 
incubated to passage 4 in 5 % oxygen, as previously 
described (Peffers et al., 2010). Briefly, they were grown 
as monolayers in Dulbecco’s modified eagles medium 
(DMEM) (Invitrogen, Paisley, UK), supplemented with 
10 % foetal calf serum, 100 units/mL penicillin, 100 mg/
mL streptomycin (all from Invitrogen, Paisley, UK) and 
500 ng/mL amphotericin B (BioWhittaker, Lonza, USA).
RNA isolation, library preparation for RNASeq and 
small RNASeq and sequencing
Total RNA was isolated from approximately two million 
cells using TRIzol (Invitrogen™ Life Technologies, 
Carlsbad, USA) (Chomczynski and Sacchi, 1987). RNA 
was purified using RNeasy spin columns with on-column 
DNase treatment (Qiagen, Crawley, UK) to remove residual 
gDNA, according to the manufacturer’s instructions. 
RNA-Seq and small RNASeq library preparations and 
sequencing was undertaken by the Centre for Genomic 
Research, University of Liverpool. Sequencing used 
the Illumina HiSeq 2000 (Illumina, San Diego, USA) 
at 2 × 100-base pair (bp) paired-end sequencing with 
v3 chemistry for RNASeq. Multiplexed size selected 
small RNA library pools were sequenced on one lane of 
the Illumina HiSeq 2500 (Illumina, San Diego, USA) at 
1 × 50 bp sequencing.
 Total RNA integrity was confirmed, using the Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
USA). Ribosomal RNA (rRNA) was depleted from 8 total 
RNA samples by using the Ribo-Zero™ rRNA Removal 
Kit (Epicentre, Madison, USA) in accordance with 
manufacturer’s instructions. For RNASeq cDNA libraries 
were prepared with the ScriptSeq v2 RNA-Seq Library 
Preparation Kit (Epicentre, Madison, USA) using 50 ng 
rRNA depleted RNA as starting material in accordance with 
manufacturer’s protocols, as previously described (Peffers 
et al., 2013a). For both RNASeq and small RNASeq 
(smallSeq), the quantity and quality of the final pools were 
assessed using Qubit (Invitrogen™ Life Technologies, 
USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, 
Santa Clara, USA). The final pooled library was diluted to 
8 pmol before hybridisation. Sequencing was undertaken 
with the Illumina HiSeq 2000 (Illumina, San Diego, USA) 
at 2 × 100-base pair (bp) paired-end sequencing with 
v3 chemistry. 1 μg of total RNA were used to prepare 
small RNA libraries using the NEBNextMultiplex Small 
RNA Library Preparation Set for Illumina (New England 
BioLabs, Ipswich, USA), according to manufacturer’s 
instructions. Following 12 cycles of amplification, the 
PCR amplified cDNA constructs were purified using the 
Qiagen QIAQuick PCR Purification kit (Qiagen, Crawley, 
UK). Multiplexed size selected small RNA library pools 
were sequenced on one lane of the Illumina HiSeq 2500 
(Illumina, San Diego, USA) at 1 x 50 bp sequencing with 
rapid-run mode chemistry.
RNA data processing
The RNASeq data was processed as previously described 
(Peffers et al., 2013a). Briefly, RNASeq sequence libraries 
were processed by using CASAVA version 1.8.2 to produce 
100 bp paired-end sequence data in fastq format. The fastq 
files were processed and quality trimming performed. The 
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trimmed R1-R2 read pairs, for each sample, were aligned 
to reference sequence (Web ref. 1) by using TopHat2 
version 2.0.10 (Kim et al., 2013) with default settings, 
except for the option –g 1. Read counts were obtained from 
the mapping results by using HTSeq-count and genome 
annotation (Web ref.2). The differential gene expression 
analysis was performed on R platform by using the edgeR 
package (Robinson et al., 2010) and focused on the contrast 
of old and young donors. The count data were normalised 
across libraries by using trimmed mean M (TMM) values 
of the default methods edgeR. The tagwise dispersions 
were estimated and then used for logFC (log2 fold 
change) estimating and testing. Differentially expressed 
genes (DEGs) were extracted by applying the threshold 
false discovery rate (FDR) of less than 0.05 to adjusted 
p values, which were generated by using Benjamini and 
Hochberg approach (Benjamini and Hochberg, 1995). 
In addition, FPKM (fragments per kilobase of exon per 
million fragments mapped) values were converted from 
count values for comparing expression levels among genes.
 For smallSeq base-calling and de-multiplexing of 
indexed reads was performed by CASAVA version 1.8.2 
(Illumina, San Diego, USA) to produce data, in fastq 
format. The raw fastq files were trimmed to remove 
Illumina adapter sequences using Cutadapt version 1.2.1 
(Martin, 2011). The option “−O 3” was set, so the 3’ end 
of any reads which matched the adapter sequence over at 
least 3 bp was trimmed. The reads were trimmed to remove 
low quality bases, using Sickle version 1.2 with a minimum 
window quality score of 20. After trimming, reads shorter 
than 10 bp were removed.
 Trimmed R1 reads were mapped to mature human 
microRNA (miRNA) and other human small RNAs 
included in Affymetrix miRNA 4.0 arrays. Reads were 
mapped to the reference sequences using Bowtie2 version 
2.1.0 (Langmead and Salzberg, 2012). Single-end mapping 
was carried out using the “very-sensitive-local” set of 
options, which increases the sensitivity and accuracy 
of the alignment relative to the default parameters. In 
addition, FPKM (fragments per kilobase of exon per 
million fragments mapped) values were converted from 
count values for comparing expression levels among small 
RNAs.
 For smallSeq DEGs and transcripts were extracted by 
applying the threshold FDR of less than 0.05 p values, 
which were generated by using Benjamini and Hochberg 
approach (Benjamini and Hochberg, 1995) and a 1.4 log2 
fold change (Log2FC). All sequence data produced in 
this study have been submitted to National Centre for 
Biotechnology Information Gene Expression Omnibus 
(NCBI GEO) under Array Express accession number 
E-MTAB-3427.
Genomic DNA isolation, bisulphite treatment and 
methylation profiling
Genomic DNA was extracted from 2 million cells using 
the SureSelect gDNA Extraction Kit (Agilent, Santa Clara, 
USA) according to manufacturer’s instructions, 500 ng of 
genomic DNA was then bisulphite converted using the EZ-
96 DNA Methylation Kit (Zymo Research, Irvine, USA). 
DNA methylation profiling of the samples was carried out 
by Cambridge Genomic Services (Cambridge, UK), using 
the Illumina Infinium HumanMethylation450 Beadchip 
array (Illumina, Inc., San Diego, USA).
Methylation data processing
GenomeStudio (Illumina Inc., San Diego, USA) was 
used to extract the raw data. GenomeStudio provides 
the methylation data as β values: β = M/(M + U) (M 
represents the fluorescent signal of the methylation probe; 
U represents the signal of the unmethylated probe). 
β values range from 0 (no methylation) to 1 (100 % 
methylation). The raw methylation data was processed 
using R (version 3.0.1) and the Watermelon package 
(version 2.12) as has been previously described (Pidsley 
et al., 2013). Probes with a detection p value > 0.01 were 
removed. Age-related differential methylation was defined 
as Benjamini-Hochberg corrected p value (Benjamini and 
Hochberg, 1995) < 0.01 and a mean methylation difference 
(Δ β score) ≥ 0.10 (10 %), as has been previously reported 
(Whitaker et al., 2013).
Protein extraction, sample preparation and mass 
spectrometry
Cell pellets containing 2 million cells were lysed using 
a probe sonicator in the presence of protease inhibitors 
(Complete protease Inhibitors EDTA-free, Roche, Lewes, 
UK. For each sample 100 μg protein was reduced, alkylated 
and trypsin digested (Peffers et al., 2013b). Liquid 
chromatography tandem mass spectrometry (LC-MS/MS) 
was performed using a NanoAcquity™ ultraperformance 
LC (Waters, Manchester, UK) on-line to an LTQ-Orbitrap 
Velos mass spectrometer (Thermo-Fisher Scientific, Hemel 
Hempstead, UK) (Peffers et al., 2013b), as previously 
described. The proteomics data were deposited to the 
ProteomeXchange Consortium (Vizcaino et al., 2014) via 
the PRIDE partner repository with the dataset identifier 
PXD001952.
 LC-MS/MS analysis  was performed using 
nanoAcquity™ ultraperformance LC (Waters, Manchester, 
UK) on-line to an LTQ-Orbitrap Velos mass spectrometer 
(Thermo-Fisher Scientific, Hemel Hempstead, UK), using 
an electrospray ionisation ion source containing a 10 μm 
coated Pico-tip emitter (Presearch Ltd., Basingstoke, 
UK). Aliquots of tryptic peptides equivalent to 300 ng 
of tendon fascicle protein were loaded onto a 180 μm 
× 20 mm C18 trap column (Waters) at 5 μL/min in 99 % 
solvent A (water plus 0.1 % formic acid) and 1 % solvent 
B (acetonitrile plus 1 % formic acid) for 5 min and 
subsequently back-flushed onto a C18 pre-equilibrated 
analytical column (75 μm × 15 mm Waters) using a 
flow rate of 0.3 μL/min. Xcalibur 2.0 software (Thermo-
Electron, Hemel Hempstead, UK) was used to operate the 
LTQ-Orbitrap Velos mass spectrometer in data-dependant 
acquisition mode. The survey scan was acquired in the 
Orbitrap with a resolving power set to 30,000 (at 400 m/z). 
MS/MS spectra were concurrently acquired on the 20 most 
intense ions from the high-resolution survey scan in the 
LTQ mass spectrometer. Charge state filtering > 1 was 
used where unassigned precursor ions were not selected 
for fragmentation. Fragmentation parameters in the LTQ 
mass spectrometer were: normalised collision energy, 30; 
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activation, 0.250; activation time, 10 ms; minimum signal 
threshold, 500 counts with isolation width 2 m/z.
Label-free quantification
For label-free quantification ageing MSCs the Thermo raw 
files of the acquired spectra from in-solution tryptic digests 
were analysed by the ProgenesisQI™ software (Version 1, 
Waters, Manchester, UK), as previously described (Peffers 
et al., 2013b). Briefly, the top five spectra for each feature 
were exported from ProgenesisQI™ and utilised for peptide 
identification in PEAKS® 7 (Bioinformtics Solutions Inc., 
Ontario, Canada) using the Unihuman database. Search 
parameters used were: 10 ppm peptide mass tolerance 
and 0.6 Da fragment mass tolerance; one missed cleavage 
allowed; fixed modification, carbamidomethylation; 
variable modifications, methionine oxidation. Proteins 
were identified with a false discovery rate (FDR) of 
1 % and a minimum of two peptides per protein. The 
resulting peptide-spectrum matches were imported into 
ProgenesisQI™ for label-free relative quantification. 
Differentially expressed proteins were defined with FDR 
p < 0.05 and ± 2-fold regulation.
Functional analysis of transcriptomic, proteomic and 
methylation data
To determine gene ontology, functional analyses, networks, 
canonical pathways and protein-protein interactions of 
age-related differentially expressed genes, methylated 
genes and proteins we performed the analyses using 
Panther Classification System (Mi et al., 2013), the 
functional analysis and clustering tool from the Database 
for Annotation, Visualisation, and Integrated Discovery 
(DAVID bioinformatics resources 6.7) (Huang et al., 2009), 
Ingenuity Pathway Analysis (IPA) (Web ref. 3) and the 
Search Tool for Retrieval of Interacting Genes/Proteins 
(STRING) tool Version 10.0 (Franceschini et al., 2013), as 
previously described (Peffers et al., 2013a; Peffers et al., 
2015). Targetscan v6.2 (Web ref. 4) was used to identify 
potential targets of miR-199.
Relative gene expression using real-time polymerase 
chain reaction (qRT-PCR)
qRT-PCR was undertaken on similarly sourced MSCs at 
P4 from an independent cohort from those used for the 
RNA-Seq analysis young; n = 3 (22.2 y ± 2.3 SD) and 
old; n = 3 (64.8 y ± 6.6 SD) using methods previously 
described (Peffers et al., 2015). Primers were either 
validated in previous publications (Bracken et al., 2003; 
Conklin et al., 2012; Martin, 2011; Peffers et al., 2015) 
and supplied by Eurogentec (Seraing, Belgium) or were 
designed and validated commercially (Primer Design, 
Southampton, UK). Steady-state transcript abundance of 
potential endogenous control genes was measured in the 
RNA-Seq data. Assays for four genes – Glutaraldehyde 
Gene Ensemble Gene ID Primer Sequences
ACANa ENSG00000157766
F: TCGAGGACAGCGAGGCC
R: TCGAGGGTGTAGCGTGTAGAGA
ALX1 ENSG00000180318
F: TTTTCACTGACTCTCTTCTTACTGG
R: ATATTGGCGGTGTGCTCCTT
COL3A1b ENSG00000168542
F: TTCTGAAATAGTCAAATACGAAATTAGA
R: CTGGGACTCATAGAATACAATCTG
EGFb ENSG00000138798
F: ACAGGAGGCTTCGGAGTT
R: AATCAGGCAATTTACTTACAATCTT
HOXB6 ENSG00000108511
F: CGCCTCCCCTCCCAATG
R: CGCATAGCCCGACGAATAG
HOXB7 ENSG00000260027
F: GTTGCCTGCCCTCCTGAG
R: GCGAGTGGTAGGTTTTGGG
MAB21L2 ENSG00000181541
F: CCGCTCAACAACTACCACAT
R: TCGTCCCAGTCCGTTTCTC
MMP16b ENSG00000156103
F: ACCCGTGTAACCCTTTGAGA
R: AACCTGAACTTCTTGAACTTGTG
RPS8 ENSG00000142937
F: CAAGAAATACCGTGCCCTGAG
R: CGATGATCCTTGTTTTACGAGTAC
PITX2 ENSG00000164093
F: AACTCCGCCCTTGAAAGACT
R: GATTCAGTGGTTTCCTTTTCTCTATA
TGFA ENSG00000163235
F: GCCACCTCCCCACAACAG
R: ATTAAACAGTTTCCCCTCCTTCAC
TGFB1 ENSG00000105329
F: CACTCCCACTCCCTCTCTC
R: GTCCCCTGTGCCTTGATG
RBL1 ENSG00000080839
F: CAGATTGTGGGTAAGCAGAAGAGTC
R: AACTGGCAACTGAGGAAAAGGC
p21 ENSG00000124762
F: GGCAGACCAGCATGACAGATTTC
R: CGGATTAGGGCTTCCTCTTGG
p85 ENSG00000145675
F: TTGCGAGGGAAGCGAGATGGC
R: TGCTGCACAAGGGAGGTGTGT
p53 ENSG00000141510
F: CTCCGGGTGAGCAGTAGG
R: TGGGGTTATAGGGAGGTCAA
a(Martin et al., 2001), b(Peffers et al., 2015) 
denote primer pairs published previously. 
F, forward; R, reverse. ACAN; aggrecan, 
ALX1; ALX homeobox 1, COL3A1; collagen 
III alpha 1, EGF; epidermal growth factor, 
HOXB6; homeobox B6, HOXB&; homeobox 
B7, MAB21L2; mab-21-like 1, MMP16; 
matrix metalloproteinase 16, KMT2A; ysine 
(K)-specific methyltransferase 2A, RPS8; 
ribosomal protein 8, PITX2; paired-like 
homeodomain 2, TGFA; transforming growth 
factor alpha, TGFB; transforming growth 
factor beta, RBL1; retinoblastoma-like 1, 
p21; cyclin-dependent kinase inhibitor 1A, 
p85; phosphoinositide-3- kinase, regulatory 
subunit 1, p53: tumour protein p53.
Table1. qRT-PCR primer sequences.
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Sample Total reads
Mapped 
Reads
% reads 
mapped
mapped 
read pairs
Singly 
mapped reads
Genes 
aligned
% genes 
aligned
msc_young3 66,306,012 60,634,324 91.45 28,916,012 2,802,300 27,930 44.23
msc_young5 69,842,190 64,120,013 91.81 30,648,269 2,823,475 28,101 44.50
msc_young6 58,743,174 51,880,907 88.32 24,653,613 2,573,681 25,548 40.45
msc_young8 58,194,714 53,513,610 91.96 25,501,727 2,510,156 28,506 45.14
msc_old3 51,067,276 46,692,381 91.43 22,140,647 2,411,087 26,381 41.77
msc_old4 57,931,724 53,115,861 91.69 25,462,506 2,190,849 27,168 43.02
msc_old5 59,896,936 53,901,889 89.99 25,288,270 3,325,349 27,929 44.22
msc_old6 58,865,142 53,602,928 91.06 25,325,008 2,952,912 28,339 44.87
Table 2. Summary of RNA sequence alignment to the human genome.
Sample Total reads
Mapped 
Reads
% reads 
mapped
% mapped 
to rRNA
Genes 
aligned
% genes 
aligned
msc_young3 9,790,558 7,875,474 80.44 5.8 1443 34.30
msc_young6 11,161,583 8,685,493 77.82 7.6 1568 37.27
msc_young8 10,438,112 8,199,841 78.56 7.8 1424 33.85
msc_old3 13,025,963 10,102,460 77.56 7.2 1542 36.65
msc_old4 10,804,811 8,544,026 79.08 5.8 1492 35.46
msc_old5 13,316,974 10,048,663 75.46 7 1643 39.05
msc_old6 8,281,321 5,926,098 71.56 11.3 1420 33.75
Table 3. Summary of small RNA sequence alignment to the human genome.
Fig.  1 .  Var ia t ion  in 
t h e  R N A S e q  d a t a 
demonstrated by principal 
componen t  ana lys i s 
(PCA) and hierarchical 
c lus te r ing .  (A )  The 
differentially abundant 
transcripts of the eight 
samples in their 2D plane 
spanned by their first two 
principle components. 
PCA plot of log2 gene 
expression data showed 
the effect of age was weak. 
(B) To complement the 
PCA, we undertook a 
hierarchical clustering of 
the samples to determine 
if the samples cluster into 
young and old groups. 
Samples from the same 
age group were closely 
correlated. (C) PCA plot 
of log2 small RNA gene 
expression showed the 
effect of age was weak. (D) 
Hierarchical clustering of 
the samples to determined 
clustering into young and 
old groups.
dehydrogenase (GAPDH), ribosomal protein 13 (RPS8), 
ribosomal protein 13 (RPS13), and ribosomal protein 16 
(RPS16) were selected as potential reference genes as 
their expression was unaltered. Stability of this panel of 
genes was assessed by applying a gene stability algorithm 
(Vandesompele et al., 2002). RPS8 was selected as the 
most stable endogenous control gene. For miR-199b 
cDNA synthesis was performed using 100 ng RNA and 
miRscript RT kit II (Qiagen, Crawley, UK) according to the 
manufacturer’s protocol. qRT-PCR analysis was performed 
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using miRScript SybrGreen Mastermix (Qiagen, Crawley, 
UK) using Rnu-6u as the endogenous control. Relative 
expression levels were calculated by using the 2−ΔCt 
method (Livak and Schmittgen, 2001). Primers pairs used 
in this study are listed (Table 1).
Western blot validation
Validation studies were undertaken with the same 
independent cohort as for the relative gene expression 
studies using methods previously described using 
20 μg protein (Peffers et al., 2013b). Membranes were 
probed with primary antibodies against the following; 
rabbit polyclonal to SOD2 (1:1000, Enzo Life Sciences, 
Exeter, UK), and anti GAPDH-horseradish peroxidase 
(HRP) conjugate (1:10,000; Sigma, Dorset, UK). A HRP 
conjugated goat anti-rabbit secondary antibody was used 
at 1:2000 (Sigma, Dorset, UK).
Statistical analysis
Statistically significant differences in relative gene 
expression were identified using a Mann-Whitney U test. 
Differences in relative band intensity in immunoblotting 
identified with a Student’s t-test. Statistical analyses were 
undertaken using S-Plus (version 7.0; Tibco Software 
Inc., Palo Alto, USA) and Excel (version 2007; Microsoft, 
Redmond, USA).
Results
Overview of RNASeq and smallSeq data
For the RNASeq data an average of 54.7 million pairs of 
100 bp paired-end reads per sample was generated that 
aligned to the human reference sequence. Mapping results 
are summarised in Table 2. Of the 63,152 human genes, 
between 40.5 % and 45.1 % had at least one read aligned. 
13,595 genes had no reads aligned from any of the samples. 
This is similar to the output of other RNA-Seq studies 
(Peffers et al., 2013a; Peffers et al., 2015).
 In the smallSeq data, an average of 8.2 million 50 bp 
single-end reads was generated. Based on data variation 
assessment, one young sample was classed as an outlier 
and so removed from subsequent data analysis. This 
represented 75.1 % of reads mapped. 2,267 human small 
RNAs (reference sequences) had at least one read aligned 
(between 1,041 and 1,586 in 7 different samples). 1,939 
of the small RNAs had no reads aligned from any of the 7 
samples. Mapping results are summarised in Table 3 and 
are similar to other small RNASeq studies (Buitrago et al., 
2015; Yang et al., 2014). Reads were used to estimate small 
RNA transcript expression of all samples using FPKM in 
order to identify the most abundant microRNAs (miRs) 
and small nucleolar RNAs (snoRNAs). Table 4 highlights 
the top 10 highly expressed small RNAs genes within each 
class.
Identification of differentially expressed genes and 
differentially spliced genes using RNASeq
For RNASeq a principal component analysis (PCA) plot 
of log2 gene expression data identified biological variation 
within both sample groups indicating that the age-effect is 
weak. The variability between old donors was greatest (Fig. 
1A). However, hierarchical clustering using a sample-to-
sample distance matrix identified clustering by age group 
(Fig. 1B).
 There were 46 differentially expressed transcribed 
elements between young and old, principally protein 
coding genes, but also three long non-coding RNAs (lncs) 
(per ± 1.4 log2 fold change, FDR < 0.05). Of these 31 were 
higher in the older MSCs and 15 were lower (Table 5).
Identification
Type of 
small RNA
Mean 
All
Standard 
Deviation All 
U63 CDBox 52627 16653
U74 CDBox 40952 15610
U50 CDBox 33773 13785
U26 CDBox 29755 8271
U81 CDBox 29553 12486
mgh28S-2409 CDBox 26763 8334
U104 CDBox 25581 6348
U58B CDBox 25280 13114
U44 CDBox 24741 12804
U30 CDBox 24549 10752
ACA18 HAcaBox 241 124
E3 HAcaBox 153 51
HBI-100 HAcaBox 152 54
ACA55 HAcaBox 146 53
ACA61 HAcaBox 116 32
U64 HAcaBox 79 25
ACA7 HAcaBox 77 28
ACA3 HAcaBox 70 21
U19 HAcaBox 70 24
E2 HAcaBox 69 30
ENSG00000222345 snoRNA 2363 1238
ENSG00000202252 snoRNA 2004 498
ENSG00000265706 snoRNA 1449 603
ENSG00000207118 snoRNA 872 327
ENSG00000222185 snoRNA 697 302
ENSG00000252787 snoRNA 157 73
ENSG00000222937 snoRNA 130 48
ENSG00000200879 snoRNA 120 34
ENSG00000199262 snoRNA 114 67
ENSG00000253067 snoRNA 82 85
U90 scaRna 78 26
U93 scaRna 69 20
ACA66 scaRna 53 9
U88 scaRna 39 21
ACA26 scaRna 30 10
U85 scaRna 21 10
U100 scaRna 7 3
U92 scaRna 7 3
ACA35 scaRna 5 3
mgU2-19-30 scaRna 2 1
hsa-miR-21-5p miRNA 15433276 2935100
hsa-miR-100-5p miRNA 8777127 1623490
hsa-let-7i-5p miRNA 2009764 522883
hsa-miR-125b-5p miRNA 1441052 479950
hsa-miR-26a-5p miRNA 1305126 384004
hsa-miR-143-3p miRNA 1197489 679965
hsa-let-7a-5p miRNA 998801 200421
hsa-miR-221-3p miRNA 881823 230714
hsa-let-7f-5p miRNA 766655 101225
hsa-miR-222-3p miRNA 670149 199778
Table 4. The top 10 most abundant small RNAs (CDBox, 
HAcaBox,scaRNAs, snoRNAs and miRs) within each class 
determined using FPKM.
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 In total, 79,387 isoforms were detected in young and 
77,189 isoforms were detected in old MSCs. No isoforms 
were differentially expressed. However, using Cuffdiff 
to calculate changes in the relative splice abundances 
by quantifying the square root of the Jensen-Shannon 
divergence on primary transcripts with at least two 
isoforms, identified 23 with differential splicing events 
(alternative splicing (AS)) (Table 6).
 For the smallSeq PCA of log2 gene expression data 
indicated the age-effect was weak. The variability between 
old donors was greatest (Fig. 1C). Hierarchical clustering 
clustered into young and old groups (Fig. 1D). The only 
differentially expressed small RNA was miR199b (FDR; 
p = 0.002, log2FC; −4.3) which was increased in older 
donors and confirmed using qRT-PCR (p = 0.0085) (Fig. 
2).
 Similar to the reports from our (Peffers et al., 2013a; 
Peffers et al., 2015) and other groups (Marioni et al., 
2008), quantification of transcripts by deep sequencing 
correlates with the results derived from qRT-PCR analyses 
reflecting the accuracy and reliability of deep sequencing 
analyses. There was no change in expression of the cellular 
senescence markers RBL1, p21, p16, p53 and p85 (Table 
7).
Gene Gene Name Log2 fold change FDR-adjusted p value 
ALX1 ALX homeobox 1 6.77 0.000
CST2 cystatin SA 4.96 0.042
PODXL podocalyxin-like 4.80 0.021
MKRN3 makorin ring finger protein 3 4.64 0.032
PITX2 paired-like homeodomain 2 4.32 0.000
CCL20 chemokine (C-C motif) ligand 20 4.25 0.025
HOXB6 homeobox B6 4.12 0.005
TGFA transforming growth factor, alpha 4.08 0.032
HOXB4 homeobox B4 3.85 0.009
HOXB7 homeobox B7 3.68 0.000
IRF6 interferon regulatory factor 6 3.62 0.042
PLAT plasminogen activator, tissue 3.25 0.001
MTND4P12 MT ND4 pseudogene 12 2.87 0.035
OSBPL6 oxysterol binding protein-like 6 1.79 0.048
EML1 echinoderm microtubule associated protein like 1 -1.43 0.009
TBX18 T-box 18 -1.98 0.009
MITF microphthalmia-associated transcription factor -2.02 0.007
FAM134B family with sequence similarity 134, member B -2.34 0.043
MAF v-maf avian musculoaponeurotic fibrosarcoma -2.65 0.002
PDE1A phosphodiesterase 1A, calmodulin-dependent -2.69 0.036
FOXP2 forkhead box P2 -3.26 0.007
DPT dermatopontin -3.55 0.036
NOS1 nitric oxide synthase 1 (neuronal) -3.66 0.010
FMO3 flavin containing monooxygenase 3 -3.89 0.011
OSR2 odd-skipped related transciption factor 2 -3.93 0.010
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1 -3.94 0.032
CD36 CD36 molecule (thrombospondin receptor) -4.08 0.007
MAB21L1 mab-21-like 1 (C. elegans) -4.42 0.005
DSG2 desmoglein 2 -4.70 0.004
FAM132B family with sequence similarity 132, member B -4.75 0.019
GMNC geminin coiled-coil domain containing -4.87 0.018
DIO2 deiodinase, iodothyronine, type II -4.89 0.036
IGSF9B immunoglobulin superfamily, member 9B -4.90 0.033
SEMA3E semaphorin 3E -5.03 0.004
EPHA7 EPH receptor A7 -5.04 0.002
TNXB tenascin XB -5.21 0.018
HAND2 heart and neural crest derivatives expressed 2 -5.30 0.023
MAB21L2 mab-21-like 2 (C. elegans) -5.49 0.000
MCF2L MCF.2 cell line derived transforming sequence-like -5.52 0.003
KLHL41 kelch-like family member 41 -5.99 0.007
RP11-670E13.5 RP11-670E13.5 -6.73 0.048
AC004870.4 AC004870.4 -7.57 0.042
OGN osteoglycin -8.13 0.007
ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide -9.25 0.001
GPC5 glypican 5 -9.61 0.036
Table 5. The DEG between young and old MSCs.
Positive log2 fold change values represent lower expression in old MSCs, negative log2 fold change values 
represent higher expression in old MSCs. FDR; false discovery rate.
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Gene ontology (GO) and IPA analysis of DEGs and 
AS genes
All DEGs (adjusted p < 0.05 and 1.4 log2 fold change) 
were analysed in DAVID. Significant annotations included 
terms ‘developmental protein’, ‘cell proliferation’ and 
skeletal system morphogenesis. The DEGs were input into 
IPA (Peffers et al., 2015). Interesting age-related features 
were determined from the gene networks inferred. The top-
scoring network was ‘embryonic development, organismal 
development, cellular function and maintenance’ (Fig. 
3). The top diseases and biological functions are shown 
in Table 8. Transforming growth factor β (TGFβ) was 
identified as a potential upstream regulator of some of 
the pathway effects identified. The genes podocalyxin 
(PODXL), homeobox B6 (HOXB6) and TGFα were 
identified as biological targets with expression pairing 
consistent with miR199 (Table 9).
 GO analyses indicated enrichment in genes associated 
with metabolic processes in 12 out of the 23 genes 
identified as undergoing AS (Fig. 4). Additionally 20 % 
of AS protein-coding genes were identified in PANTHER 
as transcription factors.
Fig. 2. Validation of age-related differential expression of 
miR199b with smallSeq using qRT-PCR. Gene expression 
is relative to Rnu-6u. Data are represented as fold change. 
Histograms represent means ± SEM * p = 0.0085. Data 
were evaluated using Student’s t-test.
Gene ID Gene Gene Name Type Locus
Square root 
Jensen-Shannon 
divergence q-value
XLOC_026797 CENPA centromere protein A protein coding 2:26987151-27023935 0.83 0.00
XLOC_033690 CNOT10 CCR4-NOT transcription complex, subunit 10 protein coding 3:32726636-32815367 0.83 0.00
XLOC_014317 DHRS4L2 dehydrogenase/reductase (SDR family) member 4 like 2 protein coding 14:24407939-24475617 0.83 0.00
XLOC_002851 EMC1 ER membrane protein complex subunit 1 protein coding 1:19536994-19586622 0.83 0.00
XLOC_034298 GTF2E1 general transcription factor IIE, polypeptide 1, alpha 56 kDa protein coding 3:120405527-120501916 0.83 0.00
XLOC_011608 ING4 inhibitor of growth family, member 4 protein coding 12:6759445-6772314 0.83 0.00
XLOC_036966 MRPL1 mitochondrial  r ibosomal protein L1 protein coding 4:78783673-78873944 0.83 0.00
XLOC_045977 NT5C3A 5’-nucleotidase, cytosolic IIIA protein coding 7:32535037-33102409 0.83 0.00
XLOC_045911 OSBPL3 oxysterol binding protein-like 3 protein coding 7:24836157-25021253 0.43 0.02
XLOC_003042 PEF1 p e n t a - E F - h a n d  d o m a i n containing 1 protein coding 1:32083286-32169920 0.83 0.00
XLOC_010138 PUS3 pseudouridylate synthase 3 protein coding 11:125753508-125773116 0.83 0.00
XLOC_023041 RAB31 R A B 3 1 ,  m e m b e r  R A S oncogene family protein coding 18:9708161-9862548 0.83 0.00
XLOC_041114 RAPGEF6 Rap guanine  nuc leo t ide exchange factor (GEF) 6 protein coding 5:130759613-131132710 0.83 0.00
XLOC_017355 SLC12A6
s o l u t e  c a r r i e r  f a m i l y 
1 2  ( p o t a s s i u m / c h l o r i d e 
transporter), member 6
protein coding 15:34525459-34630261 0.83 0.00
XLOC_021864 SREBF1 sterol regulatory element binding transcription factor 1 protein coding 17:17584786-17740325 0.83 0.00
XLOC_017808 ULK3 unc-51 like kinase 3 protein coding 15:75128456-75135687 0.83 0.00
XLOC_007014 XPNPEP1 X-prolyl  aminopeptidase (aminopeptidase P) 1, soluble protein coding 10:111624523-111683311 0.83 0.00
XLOC_040967 GJA1P1 pseudogene 5:108083522-108532542 0.83 0.00
XLOC_040175 HMGB3P22 pseudogene 5:179105583-179157926 0.83 0.00
XLOC_038137 RP11-123J14.2 pseudogene 4:77870855-77961537 0.83 0.00
XLOC_026337 CTC-301O7.4 LNC 19:49834873-49891338 0.83 0.00
XLOC_026537 CTD-2537I9.12 novel antisense 19:56165511-56186081 0.83 0.00
XLOC_041176 VTRNA2-1 vault RNA 2-1 premiR and vault RNA 5:135416159-135416286 0.83 0.00
Table 6. Table contains the genes in which there was a significant difference in splicing events in ageing MSCs.
Comparison of the DNA methylome in ageing MSCs
Unsupervised hierarchical clustering revealed that 
young and old samples are largely distinguished by their 
DNA methylome (Fig. 5). In total, 187 differentially 
methylated loci (DML) were identified, including 44 
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Fig. 3. Pathway analysis of DEGs. Top-scoring network derived from the 43 genes differentially expressed in ageing. 
Ingenuity pathway analysis (IPA) identified connective tissue development and function, embryonic development, 
organ development as the principal associated network functions with a score of 40. This is a graphical representations 
between molecules identified in our data in their respective networks. Green nodes; upregulated gene expression in 
older MSCs, red nodes; downregulated gene expression in older MSCs. Intensity of colour is related to higher fold-
change. Key to the main features in the networks is shown.
Fig. 4. Pie chart representing the occurrence of major ontological annotations associated with AS in ageing MSCs in 
biological process categories of the Panther Classification System.
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Values for quantitative real-time polymerase chain reaction (qRT-PCR) 
are the mean ± standard error of relative expression levels normalised to 
expression of RPS8 (to two decimal places). Statistical significance was 
tested by using Mann-Whitney U Test. qRT-PCR results are expressed as 
2^-DCT, NS; not significant. ACAN; aggrecan, ALX1; ALX homeobox 1, 
COL3A1; collagen III alpha 1, EGF; epidermal growth factor, HOXB6; 
homeobox B6, HOXB&; homeobox B7, MAB21L2; mab-21-like 1, 
MMP16; matrix metalloproteinase 16, RPS8; ribosomal protein 8, PITX2; 
paired-like homeodomain 2, TGFA; transforming growth factor alpha, 
TGFB; transforming growth factor beta, RBL1; retinoblastoma-like 1, 
p21; cyclin-dependent kinase inhibitor 1A, p85; phosphoinositide-3-kinase, 
regulatory subunit 1, p53; tumour protein p53, p16; tumour protein p16.
Gene name
RNA-Seq Results
Age
RT-PCR Results
p-value 
Young
Differential 
expression
Significant 
Log2FC q-value Old
ALX1
lower in old
6.77 0.00 0.55 ± 0.14 0.04 ± 0.03 0.01
PITX2 4.32 0.00 0.23 ± 0.12 0.05 ± 0.03 0.32
HOXB6 4.12 0.00 327.47 ± 62.3 0.85 ± 0.52 0.00
TGFA 4.08 0.03 1.18 ± 0.93 0.14 ± 0.02 0.04
HOXB7 3.68 0.00 6.68 ± 64.2 0.56 ± 0.43 0.04
MAB21L2 higher in old -5.49 0.00 0.25 ± 0.13 0.11 ± 0.07 0.05
ACAN
no change no change
0.84 0.17 ± 0.13 0.09 ± 0.07 NS
COL3A1 NS 0.11 ± 0.02 0.27 ± 0.12 NS
EGF NS 0.21 ± 0.18 0.17 ± 0.08 NS
MMP16 NS 11.38 ± 7.17 0.38 ± 0.35 NS
TGFB NS 0.27 ± 0.28 0.78 ± 0.46 0.02
RBL1 NS 2.8 ± 0.49 0.22 ± 0.46 NS
p21 NS 1.10 ± 0.46 1.31 ± 0.23 NS
p85 NS 0.48 ± 0.04 0.61 ± 0.13 NS
p53 NS 0.88 ± 0.22 0.83 ± 0.35 NS
p16 NS 0.00 ± 0.00 1.19 ± 1.18 NS
Table 7. Real-time polymerase chain reaction analysis of selected genes 
reveals good correlation with RNA-Seq results.
Fig. 5. Heatmap showing the unsupervised clustering 
of the 187 DMLs between the young and old samples. 
DMLs were defined as at least a 10 % difference in 
methylation between the two groups, and an FDR-
corrected p value of < 0.05. The dendrogram at the top 
shows the clustering of the loci and the dendrogram to 
the left show clustering of the samples. The methylation 
scale is shown at the top of the heatmap (1 = 100 % 
methylation, 0 = no methylation).
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Category Classification
RNASeq Methylation Proteomics
p-value 
No. 
molecules p-value 
No. 
molecules p-value 
No. 
molecules
Diseases and 
disorders
Developmental Disorder  5.36E-08 - 8.41E-3 21  3.82E-07 - 1.18E-2 18 1.40E-08 - 5.79E-3 23
Gastrointestinal Disease 1.03E-06 - 8.41E-3 14    
Connective Tissue 
Disorders 2.95E-06 - 8.41E-3 11 4.48E-06 - 1.18E-2 10 6.32E-07 - 5.79E-3 13
Skeletal and Muscular 
Disorders 2.95E-06 - 8.41E-3 12 3.82E-07 - 1.18E-2 16  
Cancer 3.12E-05 - 8.41E-3 33 9.76E-06 - 9.87E-3 11  
Neurological Disease   1.06E-04 - 1.18E-2 9  
Metabolic Disease     3.17E-11 - 5.79E-3 41
Hereditary Disorder     1.40E-08 - 5.79E-3 37
Dermatological Diseases 
and Conditions     1.49E-07 - 5.79E-3 24
Molecular 
and cellular 
functions
Cell Morphology 3.12E-06 - 8.41E-3 12     
Cellular Assembly and 
Organization 3.12E-06 - 8.41E-3 10    
Cellular Function and 
Maintenance 1.71E-05 - 8.41E-3 13    
Cellular Development  8.34E-05 - 8.41E-3 22 1.16E-05 - 1.10E-2 20  
Gene Expression 1.66E-04 - 6.31E-3 16    
Cellular Growth and 
Proliferation   1.28E-05 - 1.18E-2 20 9.31E-08 - 5.79E-3 54
Gene Expression   6.98E-05 - 1.18E-2 14  
Cell Death and Survival   3.12E-04 - 9.87E-3 19 3.11E-07 - 5.79E-3 51
Cellular Assembly and 
Organization   1.12E-03 - 5.94E-3 4  
Nucleic Acid Metabolism     1.51E-06 - 5.79E-3 19
Small Molecule 
Biochemistry     1.51E-06 - 5.79E-3 40
Energy Production     2.93E-06 - 6.72E-5 16
Physiological 
system, 
development 
and function
Embryonic Development 6.74E-13 - 8.41E-3 25 2.68E-12 - 1.23E-2 21  
Organismal Development 6.74E-13 - 8.41E-3 26 2.68E-12 - 1.23E-2 24  
Organ Development 4.75E-10 - 8.41E-3 21 3.19E-11 - 1.23E-2 19  
Tissue Development  4.75E-10 - 8.41E-3 30   4.44E-05 - 5.79E-3 31
Skeletal and Muscular 
Development, Function 8.66E-08 - 8.05E-3 17 9.02E-14 - 1.23E-2 20  9.59E-06 - 5.79E-3 22
Connective Tissue 
Development and 
Function 
   3.19E-11 - 1.18E-2 17  
Organ Morphology     9.59E-06 - 5.79E-3 23
Tissue Morphology     4.32E-05 - 5.79E-3 17
Haematological System 
Development and 
Function
     9.10E-05 - 5.79E-3 21
Table 8. Table of the top diseases and biological functions as determined by IPA for DEGs from RNASeq analysis, 
DML following methylation analysis and proteomics analysis demonstrates many similarities in the types on processes 
effected in ageing MSCs at the transcriptome, epigenetic and protein level.
Gene Gene name
Representative 
transcript
RNASeq 
qRT-PCR
miR and 
mRNA 
pairing
RNASeq 
log2FC Higher in 
PODXL podocalyxin-like NM_001018111 4.8 young no difference yes
MAB21L1 mab-21-like 1 (C. elegans) NM_005584 -4.4 old no difference no
EPHA7 EPH receptor A7 NM_004440 -5.0 old no difference no
HOXB6 homeobox B6 NM_018952 4.1 young higher in young yes
TGFA transforming growth factor, alpha NM_001099691 4.1 young higher in young yes
Table 9. Using Targetscan 6.2 for miR199 targets were identified in which the corresponding genes were also 
DEG in ageing MSCs.
Representative miRs were all hsa-miR-199a-5p. All were sites in the untranslated regions. Expression pairing 
relates to when the expression of miR199 and the corresponding target gene in the corresponding direction.
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Term Count Fold Enrichment Benjamini
GO:0048598~embryonic morphogenesis 12 16.52 0.00
GO:0048704~embryonic skeletal system morphogenesis 8 59.33 0.00
GO:0048705~skeletal system morphogenesis 9 33.97 0.00
GO:0007389~pattern specification process 11 17.42 0.00
GO:0048706~embryonic skeletal system development 8 43.92 0.00
GO:0009952~anterior/posterior pattern formation 9 27.18 0.00
GO:0001501~skeletal system development 11 14.58 0.00
GO:0043009~chordate embryonic development 11 14.05 0.00
GO:0009792~embryonic development ending in birth or egg hatching 11 13.92 0.00
GO:0003002~regionalisation 9 19.31 0.00
GO:0048562~embryonic organ morphogenesis 8 25.43 0.00
GO:0048568~embryonic organ development 8 19.66 0.00
GO:0002009~morphogenesis of an epithelium 6 25.11 0.00
GO:0048729~tissue morphogenesis 6 14.09 0.00
GO:0006355~regulation of transcription, DNA-dependent 14 3.34 0.00
GO:0051252~regulation of RNA metabolic process 14 3.26 0.00
GO:0060429~epithelium development 6 11.17 0.00
GO:0045449~regulation of transcription 16 2.60 0.01
GO:0051216~cartilage development 4 22.85 0.02
GO:0035113~embryonic appendage morphogenesis 4 19.44 0.02
GO:0030326~embryonic limb morphogenesis 4 19.44 0.02
GO:0035108~limb morphogenesis 4 17.08 0.03
GO:0035107~appendage morphogenesis 4 17.08 0.03
GO:0060173~limb development 4 16.42 0.04
GO:0048736~appendage development 4 16.42 0.04
Table 10. Significant gene ontology terms from DAVID using DML as input data. Significant primary 
term results are with a Benjamini-Hochberg adjusted p value <0.05.
Fig. 6. Top-scoring network derived from the 187 DMLs in ageing. Ingenuity pathway analysis (IPA) identified 
‘connective tissue development and function, embryonic development, organ development as the principal associated 
network functions with a score of 40. This is a graphical representation between molecules identified in our data in 
their respective networks. Green nodes; hypermethylated genes in older MSCs, red nodes; hypomethylated genes in 
older MSCs. Intensity of colour is related to higher fold-change. Key to the main features in the networks is shown.
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within CpG islands and 3 within promoters. 117 DMLs 
were hypomethylated and 70 hypermethylated in old. GO 
analysis of genes containing DMLs indicated enrichment in 
embryonic skeletal tissue morphogenesis pathways and the 
terms homeobox, developmental proteins, transcriptional 
regulation and tissue morphogenesis (Table 10). In IPA, the 
top scoring network was ‘connective tissue development 
and function, embryonic development, organ development’ 
(Fig. 6A). The top diseases and biological functions were 
similar to those identified in the RNASeq analysis (Table 
8). There was also a significant enrichment for DML of 
genes involved in differentiation of cells and connective 
tissue and the proliferation of MSCs (Fig. 7). The top 
two networks were connective tissue development and 
function, embryonic development, organ development 
(score 40), skeletal and muscular system development 
and function, embryonic development, organismal 
development (score 37).
 The methylation of gene promoters and/or enhancers 
is known to correlate with decreased gene expression 
contrastingly methylation within non-enhancer regions of 
the gene body correlates with increased gene expression 
(Jjingo et al., 2012). Therefore, we compared DEGs from 
RNASeq with location of DMLs. The DEGs HAND2, 
HOXB7 and TBX18 contained DMLs within the gene 
body. HOXB7 demonstrated decreased methylation in old 
samples with a decrease in gene expression in old; HAND2 
demonstrated an increase in methylation and concurrent 
increase in gene expression. For the genes HOXB4, 
HOXB6 and MKRN3 that contained DMLs within 
promoter regions between young and old samples only 
MKRN3 demonstrated the expected inverse relationship 
with gene expression (Table 11).
Proteomics
Protein Identification, label-free quantification
2,347 proteins were identified in combined samples from 
MSCs. Of these 777 were quantifiable using at least two 
unique peptides in Progenesis QI and 118 differentially 
expressed; 116 higher in old and 2 lower in old (Table 12A 
and B). Peptides clustered according to age with a principal 
component of 80 %. Interestingly the highest differentially 
expressed protein was superoxide dismutase 2 (SOD2) at 
20.8 higher in old MSCs (Fig.8A). This was validated with 
western blotting.
Gene ontology (GO) and IPA analysis of differentially 
expressed proteins
GO analyses indicated enrichment in genes associated 
with mitochondria, metabolic processes and transcriptional 
regulation (Fig. 8B). IPA identified the top-scoring network 
was ‘developmental disorders and metabolic disease’. 
The top diseases and biological functions included 
energy production, increased cell survival and metabolic 
diseases (Table 7). Age-related changes in oxidative state 
were identified by the canonical pathways mitochondrial 
dysfunction and oxidative phosphorylation. Interleukins-1 
and -6 were identified as upstream regulators of apoptosis, 
Gene 
ID 
DML
(B value)
Methylation 
status in old 
Log2fold change 
(RNASeq)
Gene 
expression 
status in old
Location of 
methylation 
Promoter 
or body
Data 
correlation 
HAND2 -0.66 hypermethylated -5.3 higher old 3’UTR body yes 
HOXB4 0.62 hypomethylated 3.85 lower old TSS1500 promoter no
HOXB6 0.5 hypomethylated 4.12 lower old TSS1500 promoter no
HOXB7 0.71 hypomethylated 3.68 lower old Body body yes 
MKRN3 -0.33 hypermethylated 4.64 lower old 5’UTR promoter yes 
TBX18 0.67 hypomethylated -1.98 higher old Body body no
Table 11. Summary of genes and DML correlating relationships.
The 3’UTR is encompassed in the gene body. The promoter is classified as the 5’UTR up to 1500 bp 
upstream of the start codon.
Fig. 7. Differentiation of cells and connective tissue and MSC proliferation were identified as significantly enriched 
at the DML level. Green nodes; hypermethylated genes in older MSCs, red nodes; hypomethylated genes in older 
MSCs. Intensity of colour is related to higher fold-change. Key to the main features in the networks is shown.
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Accession Anova (p) q-Value Max fold change Description
F5GYZ5 0.08 0.04 20.80 Superoxide dismutase 2, mitochondrial
F5H2U8 0.03 0.03 5.50 High mobility group AT-hook 2  
O14558 0.00 0.00 4.86 Heat shock protein beta-6  
B4DJ51 0.01 0.03 4.51 Calmodulin 1 , isoform CRA_a  
Q9BS40 0.01 0.03 4.51 Latexin  
P27487 0.02 0.03 3.65 Dipeptidyl peptidase 4  
F5H157 0.01 0.03 3.21 RAB35, member RAS oncogene family
Q6IBC4 0.04 0.03 3.19 NADH dehydrogenase Fe-S protein 6, 13kDa , isoform CRA_a  
Q9Y383 0.03 0.03 3.13 Putative RNA-binding protein Luc7-like 2  
P61604 0.02 0.03 3.09 10 kDa heat shock protein
Q16647 0.02 0.03 3.06 Prostacyclin synthase  
E9PH29 0.05 0.03 2.99 Peroxiredoxin 3  
Q6FHF5 0.00 0.02 2.98 Proliferating cell nuclear antigen
Q12765 0.01 0.02 2.94 Secernin-1 
D3DUZ3 0.02 0.03 2.93 Interferon, gamma-inducible protein 16, isoform CRA_a 
Q02952 0.02 0.03 2.88 A-kinase anchor protein 12  
F5H801 0.03 0.03 2.87 Oxoglutarate (alpha-ketoglutarate) dehydrogenase 
A2A274 0.01 0.02 2.86 Aconitase 2
B3KQK4 0.00 0.01 2.84  highly similar to Cathepsin L 
Q59GA0 0.03 0.03 2.84 Thy-1 cell surface antigen variant
P08559 0.08 0.04 2.83 Pyruvate dehydrogenase E1 component subunit alpha, somatic form
A8K1Z2 0.05 0.03 2.78 highly similar to  glycerol-3-phosphate dehydrogenase 2 
B4DT77 0.00 0.02 2.78 Annexin  
Q5TBU5 0.00 0.02 2.77 Adipose specific 2 
Q9Y499 0.03 0.03 2.75  clone 23742 
A8K5W7 0.01 0.02 2.73  highly similar to  mitochondrial isoleucine tRNA synthetase
Q0QEY7 0.01 0.02 2.69 Succinate dehydrogenase complex subunit B
P00367 0.00 0.02 2.64 Glutamate dehydrogenase 1
P42224 0.02 0.03 2.63 Signal transducer and activator of transcription 1-alpha/beta
B4DE89 0.00 0.02 2.63  highly similar to Tripeptidyl-peptidase 1 
P10809 0.01 0.02 2.62 60 kDa heat shock protein
B2R5M8 0.05 0.04 2.60 Isocitrate dehydrogenase 
Q59EK1 0.05 0.03 2.58 Adducin 3 isoform a variant
B4DUL5 0.04 0.03 2.58 highly similar to Ubiquinol-cytochrome-c reductase complex coreprotein I
P30084 0.01 0.02 2.57 Enoyl-CoA hydratase, 
B4DDM6 0.02 0.03 2.54 Budding uninhibited by benzimidazoles 3 homolog 
B4DPJ2 0.03 0.03 2.54 Annexin  
P24752 0.01 0.02 2.52 Acetyl-CoA acetyltransferase
Q9UQ80 0.00 0.02 2.52 Proliferation-associated protein 2G4 
Q9Y5X1 0.00 0.02 2.52 Sorting nexin-9  
P28066 0.01 0.03 2.50 Proteasome subunit alpha type-5  
F8VY04 0.04 0.03 2.49 Adenylate kinase 2
Q2TNI1 0.02 0.03 2.48 Caveolin  
E5KNY5 0.07 0.04 2.48 Leucine-rich PPR-motif containing
O95425 0.03 0.03 2.46 Supervillin 
F5GZ16 0.04 0.03 2.44 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 
P06703 0.05 0.03 2.44 Protein S100-A6  
B4DUC1 0.06 0.04 2.43 Uncharacterized protein  
Q969G5 0.02 0.03 2.42 Protein kinase C delta-binding protein  
O60437 0.01 0.02 2.41 Periplakin  
C9JGC2 0.02 0.03 2.40 Uncharacterized protein  
Q63ZY3 0.00 0.01 2.40 KN motif and ankyrin repeat domain-containing protein 2  
O00479 0.02 0.03 2.39 High mobility group nucleosome-binding domain-containing protein 4
E9PFT9 0.07 0.04 2.38 Transmembrane protein 119  
F5H4I0 0.00 0.02 2.37 Dihydrolipoyl dehydrogenase 
B4E2W0 0.04 0.03 2.37 Hydroxyacyl-CoA dehydrogenase B
E9PQW4 0.00 0.02 2.36 Mitogen-activated protein kinase 3  
Q9Y6N5 0.03 0.03 2.36 Sulfide:quinone oxidoreductase, 
P10606 0.03 0.03 2.35 Cytochrome c oxidase subunit 5B, 
P62942 0.01 0.03 2.34 Peptidyl-prolyl cis-trans isomerase 
Q6NZI2 0.01 0.02 2.34 Polymerase I and transcript release factor 
P45880 0.03 0.03 2.33 Voltage-dependent anion-selective channel protein 2  
Table 12A. Differentially expressed proteins identified following database search using at least two unique 
peptides.
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Accession Anova (p) q-Value Max fold change Description
Q53HQ8 0.05 0.04 2.32 Granulin variant 
Q86TY5 0.03 0.03 2.32 Full-length cDNA clone CS0DI041YE05 of Placenta   
F8VU90 0.04 0.03 2.32 Peptidyl-prolyl cis-trans isomerase  
P02545 0.01 0.03 2.29 Prelamin-A/C  
P14854 0.00 0.02 2.28 Cytochrome c oxidase subunit 6B1  
P61106 0.04 0.03 2.27 Ras-related protein Rab-14  
B4DZ88 0.02 0.03 2.25 KTN1 protein
Q92973 0.03 0.03 2.24 Transportin-1  
Q99436 0.00 0.02 2.22 Proteasome subunit beta type-7  
B4E2K4 0.06 0.04 2.22 cDNA FLJ54576, highly similar to Aspartyl/asparaginyl beta-hydroxylase 
P40939 0.00 0.02 2.22 Trifunctional enzyme subunit alpha
P13073 0.07 0.04 2.19 Cytochrome c oxidase subunit 4 isoform 1
Q53R19 0.08 0.04 2.19 Actin related protein 2/3 complex, subunit 2, 34kDa, isoform CRA_a  
P15374 0.04 0.03 2.19 Ubiquitin carboxyl-terminal hydrolase isozyme L3  
Q549N0 0.04 0.03 2.17 Cofilin 2 (Muscle), isoform CRA_a 
H0YLU7 0.03 0.03 2.17 Electron-transfer-flavoprotein, alpha polypeptide
E9PFH8 0.01 0.03 2.17 Sjogren syndrome antigen B 
E9PRJ8 0.05 0.03 2.16 CD81 molecule 
Q96C19 0.00 0.02 2.16 EF-hand domain-containing protein D2  
E7EW69 0.01 0.02 2.15 Septin 10  
Q9Y2W1 0.05 0.04 2.15 Thyroid hormone receptor-associated protein 3  
B4DRB7 0.09 0.04 2.14 highly similar to Proactivator polypeptide  
Q03252 0.02 0.03 2.14 Lamin-B2  
Q6FHN3 0.08 0.04 2.14 Nucleoside diphosphate kinase 
B3KTN4 0.02 0.03 2.13 Citrate synthase  
Q6FHP5 0.00 0.02 2.13 PHB protein
A6XMH5 0.06 0.04 2.12 Beta-2-microglobulin  
P31949 0.08 0.04 2.12 Protein S100-A11  
Q9H3P7 0.06 0.04 2.12 Golgi resident protein GCP60  
Q76LA1 0.06 0.04 2.11 CSTB protein  
Q07812 0.04 0.03 2.11 Apoptosis regulator BAX  
Q15075 0.01 0.03 2.10 Early endosome antigen 1  
Q9Y230 0.02 0.03 2.10 RuvB-like 2  
E9PKT8 0.02 0.03 2.09 Nucleosome assembly protein 1-like 
P04083 0.02 0.03 2.07 Annexin A1  
P35908 0.00 0.02 2.07 Keratin, type II cytoskeletal 2 epidermal
Q5TB52 0.03 0.03 2.07 3’-phosphoadenosine 5’-phosphosulfate synthase 2  
Q9NX63 0.06 0.04 2.07 Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, 
A8K7A4 0.01 0.03 2.07 highly similar to  methionine adenosyltransferase II, beta, transcript variant 2
B2R984 0.04 0.03 2.06 highly similar to  histone 1
P25398 0.06 0.04 2.06 40S ribosomal protein S12  
Q6IBA2 0.00 0.02 2.06 PC4 protein  
P04632 0.08 0.04 2.06 Calpain small subunit 1 
P06576 0.00 0.02 2.05 ATP synthase subunit beta
F8W118 0.03 0.03 2.04 Nucleosome assembly protein 1-like 
Q53HG3 0.00 0.02 2.04 Peroxisomal D3,D2-enoyl-CoA isomerase isoform 1 variant
Q9Y6M1 0.06 0.04 2.04 Insulin-like growth factor 2 mRNA-binding protein 2  
P08670 0.00 0.02 2.03 Vimentin
F5GY50 0.08 0.04 2.03 Prostaglandin reductase 1
Q9Y6C9 0.07 0.04 2.03 Mitochondrial carrier homolog 2  
Q549C5 0.03 0.03 2.02 HCG2010808, isoform CRA_a 
B4DFP5 0.05 0.03 2.01 highly similar to Hepatocyte growth factor-regulated tyrosine kinase substrate  
A8K766 0.04 0.03 2.01 highly similar to  electron-transfer-flavoprotein, beta polypeptide
G3V279 0.01 0.02 2.01 Enhancer of rudimentary homolog 
Q9UBG0 0.06 0.04 -2.00 C-type mannose receptor 2  
P52943 0.03 0.03 -2.06 Cysteine-rich protein 2  
Table 12B. Differentially expressed proteins identified following database search using at least two unique peptides.
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Fig. 8. Proteomic changes associated with MSC ageing; (A) Increased SOD2 protein expression as determined by 
western blotting of young and old MSCs. Western blot analysis of SOD2 relative to GAPDH demonstrated an increase 
in SOD2 with age confirming label-free quantification results. (B) Pie chart representing the occurrence of major 
ontological annotations associated with differentially expressed proteins in ageing MSCs for i.) biological processes 
and ii) molecular function categories of the Panther Classification System. (C) Interleukins-1 and -6 were identified as 
upstream regulators of a set of differentially expressed proteins leading to activation of apoptosis, cell proliferation and 
mitochondrial damage. (D) One of the top regulator effects networks, which explains how predicted upstream regulators 
cause the observed changes in protein expression explaining phenotypic or functional outcomes downstream. These causal 
hypotheses take the form of directionally coherent networks formed from the merger of upstream regulator networks 
with downstream effects networks. Mitogen activated protein kinase 1 (MAPK1) and peroxisome proliferator-activated 
receptor gamma (PPARG) were identified as upstream regulators of downstream inhibition of fibrosis and organismal 
death but activation of cell survival through a set of nine differentially expressed proteins.
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cell proliferation and mitochondrial damage activation 
(Fig. 8C). Top regulatory effects networks included cell 
survival and reduced fibrosis in ageing (Fig. 8D).
Fig. 9 summaries major findings from the study.
Discussion
Major sources of cells for musculoskeletal tissue 
regeneration (both in vivo and in vitro) are adult MSCs 
(Natsu et al., 2004; Shirley et al., 2005). Recent studies 
have revealed that MSC cell biology is influenced by 
biological ageing (Campagnoli et al., 2001) with MSCs 
from older donors having a shorter life-span, and a reduced 
proliferative and differentiation potential (Sethe et al., 
2006). Thus age-related changes to their functionality 
may contribute to musculoskeletal ageing; a major factor 
in many musculoskeletal diseases. Our study aimed to 
increase our understanding of age-related changes in the 
systems of biological components of MSCs at the RNA, 
epigenetic and protein level. This has identified common 
networks across scales enabling a ‘big picture view’ of 
MSC ageing.
 Previous investigations on ageing MSCs have been 
undertaken on a variety of subsets of stem cells with 
variable potentials and characteristics. The combinatorial 
effects of genomic, epigenetic and proteomic changes lead 
to a decline in cellular function, which in turn contributes 
to tissue dysfunction and ageing. Here, we used young and 
old MSCs that had been tested for ‘stemness’ at a number 
of levels, including analysis of a comprehensive panel of 
markers and differentiation assays, performed for each lot 
prior to inclusion. Furthermore, as the site of extraction 
can affect cell behaviour (Bork et al., 2010; Matsubara et 
al., 2004), we used MSCs derived from alveolar bone. As 
low oxygen tension improves MSC vitality and metabolic 
state in culture (Estrada et al., 2012; Knuth et al., 2013), 
all cell culture were undertaken in 5 % oxygen tension. 
Finally, as challenges arise in distinguishing ageing in 
vivo and in vitro, we used the same passage number for 
all donors from identical seeding densities and confluence 
that can influence cellular ageing (Wagner et al., 2010). It 
is worth noting that whilst one study found no difference 
between passage 2 and 10 in proliferation capacity and 
differentiation potential in MSCs (Bruder et al., 1997), 
others demonstrated a reduction in colony forming units 
from passage 4 (Peter et al., 2012).
 There is a detrimental effect on MSC clonogenicity, 
proliferation capacity and differentiation potential when 
expansion is undertaken. Our studies were undertaken 
on ageing MSCs in in vitro conditions, which will 
produce different results from MSCs within an in vivo 
physiological environment. However, in order to obtain 
enough cells to undertake the systems biology approach 
used in our study, this was required. It would be beneficial 
to repeat the study on freshly isolated MSCs, in order to 
predict their ageing before expansion. As insufficient cell 
numbers would be problematic, this could be undertaken 
in a more targeted workflow in the future, but was beyond 
the scope of this study. Furthermore, although we have 
identified molecular changes at a number of levels, a 
validation of the system is required. As ageing can affect 
MSC differentiation potential in further work we have 
undertaken transcriptomic, proteomic and epigenetic 
analysis of changes in chondrogenic, osteogenic and 
tenogenic constructs produced from the young and old 
MSCs utilised in this study.
 One of the main challenges of this study was the 
integration of the different types of data. We used network 
analysis and annotation of the pathways identified. 
However, we were unable to integrate key environmental 
factors such as nutrition and other lifestyle factors; 
affecting the pathways due to limited information on the 
donors. These factors can change molecular measurements. 
Other potential limitations include small sample size 
and significance threshold filtering, which can affect 
the subsequent pathway/network analysis. Additional 
parameters, such as histone modification, would benefit the 
study but this was beyond the financial scope of the study. 
Dynamic histone methylation can contribute to the ageing 
process through influencing DNA repair and transcriptional 
Fig. 9. Summary diagram of MSC 
ageing using multi-level analysis; DNA 
(DNA methylation), RNA (RNASeq), 
MicroRNA 199 (miR199) and protein 
level. Ontology terms in the bubbles 
are significantly enriched terms derived 
following bioinformatics using IPA/
DAVID/PANTHER. Connections 
between each level and general ontology 
term are red for RNA, blue for DML and 
green for protein.
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regulation of ageing processes (reviewed by: McCauley 
and Dang, 2014).
 Our study found weak age-related effects on expression 
at the miR level. Despite this, an added benefit of using 
smallSeq was that we identified for the first time, in an 
unbiased manner, a catalogue of miRs and small nucleolar 
RNAs expressed in MSCs and their relative expression 
levels which will be a useful tool in future studies. Results 
contrast to a recent study in monkeys that identified 40 
differentially expressed miRs in ageing by microarray (Yu 
et al., 2011). This could be due to species, platform and 
workflow differences. The differential expression of miR-
199 has been previously reported in this study and human 
MSC ageing (Alt et al., 2012). Here we demonstrate the 
age-related increase in miR-199b-5p expression. Analysis 
of miR predicted target genes and networks demonstrates 
that miR-199b-5p may be involved in regulating SIRT1, 
TGFα and PODXL. The expression of other predicted 
targets: MAB21L and EPHA7, was negatively correlated 
with that of miR-199b-5p during ageing, suggesting that 
these may indeed be targets. Interestingly, TGFα has 
been shown to mediate secretion of VEGFA by MSCs, 
positively contributing to processes like wound healing 
and injury response (Wang et al., 2008). Moreover, SIRT1 
appears to regulate the differentiation of MSCs (Simic et 
al., 2013) and their long-term growth (Yuan et al., 2012). 
Together, these data support the hypothesis that age-related 
upregulation of miR-199b-5p expression in MSCs may 
contribute to age-related deterioration of MSC function 
through regulating key genes.
 In transcriptomic studies, it is difficult to justify 
each individual change at the gene level. Generally, it 
is more informative to look at the changes as a whole. 
Therefore, we used gene ontology and network analysis 
tools. However, there are a few interesting findings for 
the some individual genes. We investigated the levels of 
gene expression previously reported to be associated with 
cellular senescence: p16, p21, Rb, p53 and p85. Previous 
studies have found increased levels of p21 and p53 in ageing 
MSCs (Stolzing et al., 2008; Zhou et al., 2008), although 
none of these were significantly changed in ageing in this 
study. This may be due to differences in individual studies 
or the variability in the expression between individuals, 
especially apparent in MSCs from older individuals. ALX1 
has the most reduced expression change in old. This gene 
is important in skeletal development and has previously 
demonstrated to have increased expression in old tendon 
(Peffers et al., 2015) and in bone-marrow-derived MSCs 
compared to those derived from umbilical cord (Hsieh 
et al., 2010). The most highly DEGs in the old were 
CPC5 (involved in cell division and growth regulation), 
ADH1B (an enzyme able to metabolise many substrates) 
and OGN (an osteoblastic differentiation gene). We found 
age-related changes in gene profiles included differences 
in cell proliferation, signalling, function and maintenance. 
These changes suggest an age-related loss in MSCs ability 
to respond to biological cues. In addition, there was a 
dysregulation of transcription factors at the transcript 
and AS level in ageing with a reduction in expression of 
ALX1, PITX2, HOXB6, HOXB7, IRF6 and an increased 
expression of TBX18 and FOXP2 in ageing. Transcription 
factors, including HOX genes have been implicated in 
ageing of tissues (Stelnicki et al., 1998) including tendon 
(Peffers et al., 2015), and heart (Bodyak et al., 2002). 
Interestingly, HOX genes are an intrinsic property of 
MSCs and play a role in cellular identity, are required 
for tissue appropriate regeneration (Ackema and Charite, 
2008; Sagi et al., 2012) and may be involved in the timing 
of ageing (Bork et al., 2010). Loss of cellular identity, 
through alterations in HOX gene expression (Trivedi et 
al., 2011), results in aberrant cellular homeostasis and 
age-related functional deterioration. Conversely, HOX-
mediated transcriptional memory limits stem cell-mediated 
tissue regeneration (Chang, 2009). Potentially, the altered 
expression in ageing may affect the differentiation potential 
of older MSCs particularly in relation to osteogenesis (Shi 
et al., 1999). This has particular relevance to both tissue 
engineering and musculoskeletal repair in ageing.
 There is a disruption of splicing with ageing (Harries et 
al., 2011). We have previously observed an age-associated 
disruption to the balance of alternatively expressed 
isoforms for selected genes in tendon ageing (Peffers 
et al., 2015). Alterations in the splicing patterns of the 
mRNA transcripts contribute to some age-related diseases, 
including Hutchison Gilford Progeria syndrome (Eriksson 
et al., 2003) and Alzheimer’s (Chen et al., 2010). Thus, 
whilst most MSCs may be expressing genes at comparable 
levels in MSC ageing, there are also differences in the 
relative balance of splice products or increase in the 
occurrence of atypical transcripts. Interestingly, ontology 
analysis identified AS genes altered in ageing primarily 
affected metabolic processes similar to that in ageing brain 
(Tollervey et al., 2011).
 We identified two differentially regulated LNCs in 
MSC ageing; AC004870.4 and RP11-670E13.5. LNCs 
(Long Noncoding RNA) are a diverse group of non-protein 
coding RNA molecules  longer than 200 nucleotides 
whose expression is developmentally regulated and both 
cell and tissue specific. The function of the majority of 
LNCs is unknown. However, they have been implicated 
in many diseases (Ponting et al., 2009). Studies have 
revealed that LNCs have significant roles in biological 
processes, including, transcription, imprinting, chromatin 
modification (Kung et al., 2013). Furthermore, they are 
important in controlling tissue differentiation (Hu et al., 
2012). Previously, a study has identified differentially 
expressed LNCs in bone marrow versus periodontal 
ligament derived MSCs from young donors (Dong et 
al., 2014). The expression of RP11-670E13.5 has been 
previously identified in bone marrow (Uhlen et al., 2015). 
However, there is no expression data for RP11-670E13.5, 
also known as lnc-DGKE-2, in MSCs. There may be 
a significant role for LNCs in phenotypic regulators of 
MSC differentiation and they could aid the establishment 
of lineage specification through independent mechanisms 
(Tye et al., 2015). LNCs represent potential biomarkers of 
disease and novel therapeutic targets for ageing, but much 
work is needed to elucidate their roles in MSC ageing.
 Epigenetic processes have been implicated in 
ageing and age-related musculoskeletal diseases such as 
osteoarthritis (Rushton et al., 2014). Here, we analysed 
DNA methylation; the most characterised epigenetic 
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mechanism, which is primarily involved in gene regulation. 
Alterations in DML within ageing tissues (Calvanese et 
al., 2009; Zykovich et al., 2014) and cells (Fernandez et 
al., 2012), as well as aged MSCs (Bork et al., 2010), and 
following successive in vitro culture (reviewed (Bentivegna 
et al., 2013)). Our study provides the most comprehensive 
DNA methylation analysis of ageing MSCs, to date, 
using the HumanMethylation 450 Beadchip array. This 
has advantages over the 27K array used previously (Bork 
et al., 2010) as the 27K array contains probes within 
promoters only, whereas the 450K array includes probes 
within multiple genomic features as well as less dense 
CpG regions. Most methylation changes occurring in 
disease occur in the less dense CpG regions thus additional 
probes on the 450K array is advantageous. However, there 
was significant concordance with the results from this 
study. There was a global hypomethylation in ageing, as 
described previously (Calvanese et al., 2009). Methylation 
changes in the study were associated with HOX genes, 
similar to other studies (Bork et al., 2010), the expression 
of which is tightly regulated temporally during vertebrate 
development. An association between HOX genes and 
longevity has been previously proposed (Venkataraman 
and Futerman, 2002). HOXB4, HOXB6 and HOXB7 
were also DEGs in the RNASeq study. However, only for 
HOXB7 did DEG correlate (reduced in old) with DNA 
hypomethylation within the gene body. Despite this, the 
dysregulation of HOX genes at the mRNA and epigenetic 
level consolidate their role in MSC ageing.
 We identified many DMLs in genes involved in 
differentiation of cells and connective tissue as well as the 
proliferation of MSCs. The latter was also identified at the 
transcriptomic level. Methylation changes at specific CpG 
sites can affect MSC differentiation (Noer et al., 2007; 
Zimmermann et al., 2008), whilst alterations in MSC 
potential have been previously noted (Khan and Marsh, 
2009; Sethe et al., 2006).
 We did not observe a general correlation of DNA 
methylation with differentially expressed genes. This 
could be due to the differing sensitivities of the two 
platforms. It is commonly accepted that DNA methylation 
regulates gene expression. However, the effect of DNA 
methylation on gene expression is dependent upon the 
site of methylation. DNA methylation within the gene 
body or 3’untranslated region (UTR) of a gene generally 
positively correlates with gene expression, whereas 
methylation in the promoter is inversely correlated with 
gene expression. Others have hypothesised that DMLs 
at specific CpG sites does not inevitably correlate with 
gene expression changes. Significant gene expression 
fold-changes can only be anticipated if the CpG sites are 
principally methylated and that selective modification of 
certain promoter regions activate or inactivate binding 
of transcription regulators (Bork et al., 2010). Further 
suggestions for the lack of correlation could be that a 
minimal number of altered DMLs are required in order to 
correlate with gene expression changes (Zykovich et al., 
2014) or that methylation changes may reflect historical 
gene expression changes.
 Interestingly, a recent report on reprogramming of 
old MSCs into induced pluripotent stem cells (iPS) and 
their subsequent re-differentiation into MSCs, indicated a 
reduction in some age-related MSCs features. Epigenetic 
recapitulation was maintained, with the age-affected DNA 
methylation accumulation remaining reset in iPS-MSCs 
(Frobel et al., 2014).
 The maintenance of the MSC proteome is imperative 
for assuring stem cell identity. Label-free quantification 
provided the most comprehensive proteomic analysis of 
ageing MSCs phenotype to date. Whilst studies imply that 
alterations in mRNA levels are a significant factor in the 
determination of protein changes, gene expression – as 
reflected by mRNA – is correlated with protein 40 % of 
the time (Web ref. 5). Protein expression is subject to a 
diversity of regulations of transcription and translation, 
including mRNA and protein half-life, translation 
rate, post-translational modifications and subcellular 
localisation. Furthermore, differences in sensitivity 
between platforms can also account for differences. In 
this study, there was minimal overlap at the RNA and 
protein at the individual molecule level but there were 
similarities at the functional level for many changes; 
metabolism, transcriptional regulation, energy metabolism, 
development, cell proliferation and cell survival in MSC 
ageing.
 There was an age-related increase in proteins involved 
in anti-oxidant changes, energy, nucleic acid and fatty-acid 
metabolism, musculoskeletal abnormalities, increased cell 
survival and reduced cell death. A number of inflammatory 
cytokines were upregulated in ageing (TGFα at the gene 
level) or identified as upstream regulators at the gene (IL6, 
TNF) and protein level (IL4, IL6, IL1β). Together, these 
findings, indicate that MSCs undergo inflamm-ageing 
(reviewed by: Lepperdinger, 2011). Furthermore, similar 
to others, mitochondrial ageing (Kasper et al., 2009) was 
demonstrated.
 Mitochondrial dysfunction is a hallmark of the ageing 
phenotype, and alterations in redox balance may, in 
part, explain the observed reduction in cellular function 
associated with age (Chan, 2006). The differences in 
mitochondrial protein expression could be indicative of 
potentially dysfunctional mitochondrial alterations in 
ageing. A key finding of this study was a large increase 
in mitochondrial superoxide dismutase (SOD2) protein 
expression in ageing, which is in contrast to others (Duscher 
et al., 2014; Stolzing et al., 2008). The mitochondria are 
a primary source of reactive oxygen species (ROS) and 
SOD2 represents the principle antioxidant molecule 
that scavenges mitochondrial superoxide, thus of key 
importance in maintaining redox balance (Miao and St 
Clair, 2009). An increase in SOD2 protein was associated 
with an increase in mitochondrial peroxiredoxin 3, a key 
scavenger of H2O2, which suggests that in this study, the 
antioxidant capacity of ageing cells increases similar 
to rat ageing cartilage (Fu et al., 2013), but in contrast 
to other studies (Duscher et al., 2014; Stolzing et al., 
2008). This observation may be a compensatory response 
by the cell to restore oxidative balance, given that our 
data also demonstrate increased protein expression of 
many mitochondrial proteins. This includes members of 
the electron transport chain; crucial for mitochondrial 
homeostasis. Whether or not the increase in mitochondrial 
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antioxidant proteins correlates with increased activity is 
beyond the scope of this study, but represents a future 
avenue of research for our group. Alternatively, the 
dramatic increase in SOD2 levels may be evidence of 
mitochondrial dysfunction, potentially exposing the cell 
to large amounts of H2O2, which could enhance oxidative 
stress and cause aberrant H2O2-mediated redox signalling 
(Veal et al., 2007).
 There was a reduction in proteasome subunits PSMB7, 
PSMA5 and PSMD2 in ageing MSCs. This has previously 
been associated with reduced proteasome activity in 
ageing fibroblasts (Hwang et al., 2007). Furthermore, 
PSMB7 silencing induces autophagy in cardiomyocytes 
(Kyrychenko et al., 2014). Cellular damage and dysfunction 
can be caused by defects in proteostasis, resulting in the 
accumulation of damaged proteins (Bucciantini et al., 
2002). The age-dependant deficits evident here in the 
proteasome subunits may affect both protein quality and 
autophagy, contributing to MSC ageing.
Conclusion
Our data suggest that age-related changes in MSCs result 
in impaired therapeutic potential of aged progenitor cells. 
These results have significant implications for therapeutic 
cell source decisions (autologous or allogeneic) revealing 
the necessity of approaches to improve functionality of 
ageing MSCs.
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Discussion with Reviewers
Reviewer I: Do you think this work could offer the base for 
future studies to predict the age of freshly isolated MSC?
Authors: This study was undertaken to determine the 
difference at a systems level (transcripts, epigenetic and 
protein) of chronological ageing on bone marrow derived 
MSCs. This is of course not the same as looking at in vitro 
ageing. Age-related functional and biological alterations 
in MSCs were identified. The ages used in the study 
were in two distinct groups twenties and sixties, due to 
limitations in resources, but provides some interesting 
features not previously interrogated, namely chronological 
MSC ageing. It would be interesting in future studies 
to look at age groups between these extremes and also 
beyond, to perhaps eighties, to get a more refined idea of 
transcript, protein and epigenetic changes through age and 
their consequences. From the study, one could develop 
(following additional recruitment of donors through a 
wider age range and with further validation) a panel of 
molecules that may be able to predict the phenotypic age 
of the MSCs from a particular donor. Given the age-related 
changes in MSCs found in this study with potential for 
impaired therapeutic capacity of aged progenitor cells, 
these data could aid in the choice of MSCs (autologous 
or allogeneic) in particular patients that are undergoing 
cartilage or tendon repair.
Reviewer I: Which functional assay would you use to 
validate your results?
Authors: This is a very good question. The implications 
of the study are two-fold. Firstly, the results suggest that 
age-related dysregulation at all molecular levels tested in 
MSCs may have consequences in the ability of a damaged 
musculoskeletal tissue to repair and the mechanical 
properties of that tissue and thus functionality. Secondly, 
there will be a consequential effect on the content, 
viability and functionality of tissue engineered constructs 
made from ageing MSCs that are used in cartilage or 
tendon repair therapies. Functional assay, on a practical 
level, should determine the effects of the deterioration in 
regenerative potential on ageing. This question has partially 
been addressed in further studies, which are not alluded to 
in this study and are not yet unpublished. Chondrogenic 
pellets, osteogenic 2D constructs and tendon 3D fibrin 
constructs from the young and old MScs were produced 
and then subjected to the same platforms the MSCs were 
subject to (RNASeq, miRNASeq, methylation array and 
proteomics). Similar and distinct age-related pathways 
were identified. Further studies, which have not been 
undertaken but could be performed, would then look at the 
mechanical competence of the tissue-engineered constructs 
to establish the age-related effect and thus translational 
impact. These further studies did not look at differentiation 
potential, as there was only a single end-stage time point. 
However, other functional tests could ascertain if there 
was a difference in differentiation potential by comparing 
chondrogenic, osteogenic and tenogenic markers (the latter 
is difficult, as these are not well defined in tendon).
Reviewer II: Why were epigenetic histone marks and 
other ncRNAs (such as lncRNAs) besides miRNAs not 
investigated?
Authors: We tried to include as many ‘molecular’ platforms 
as possible in our small study, given financial constraints. 
Therefore, histone marks were not assessed in this study 
but would be beneficial. With regards to long non-coding 
RNAs analysis, we did in fact identify two differentially 
expressed lncRNAs (LNCs) in this study; AC004870.4 
and RP11-670E13.5. The size selection in the library 
preparations for RNASeq enables LNCs to be identified and 
the data analysed. LNCs are a diverse group of non-protein 
coding RNA molecules longer than 200 nucleotides, whose 
expression is developmentally regulated and both cell and 
tissue specific. The function of the majority of LNCs is 
unknown. However, they have been implicated in many 
diseases. Studies have revealed that LNCs have significant 
roles in biological processes, including, transcription, 
imprinting, chromatin modification. Furthermore, they are 
important in controlling tissue differentiation. Previously a 
group has identified differentially expressed LNCs in bone 
marrow versus periodontal ligament derived MSCs from 
young donors. Here, RP11-670E13.5 was identified to be 
differentially expressed in bone marrow. However, there 
is no expression data for RP11-670E13.5 also known as 
lnc-DGKE-2 in MSCs. There may be a significant role for 
LNCs in phenotypic regulators of MSC differentiation and 
they could aid the establishment of lineage specification 
through independent mechanisms. LNCs represent 
potential biomarkers of disease and novel therapeutic 
targets for ageing, but much work is needed to elucidate 
their roles in MSC ageing.
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